Fundamental Analysis of OCUGEN INC(NASDAQ:OCGN) stock

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to OCGN. OCGN was compared to 587 industry peers in the Biotechnology industry. OCGN has a bad profitability rating. Also its financial health evaluation is rather negative. OCGN does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

OCGN had negative earnings in the past year.

In the past year OCGN has reported a negative cash flow from operations.

In the past 5 years OCGN always reported negative net income.

OCGN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -97.73%, OCGN is doing worse than 77.61% of the companies in the same industry.

OCGN has a worse Return On Equity (-155.51%) than 67.35% of its industry peers.

		Industry Rank	Sector Rank
ROA	-97.73%
ROE	-155.51%
ROIC	N/A

ROA(3y)-75.93%

ROA(5y)-94.74%

ROE(3y)-104.39%

ROE(5y)-131.26%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OCGN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OCGN does not have a ROIC to compare to the WACC, probably because it is not profitable.

OCGN has more shares outstanding than it did 1 year ago.

OCGN has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, OCGN has a worse debt to assets ratio.

2.2 Solvency

OCGN has an Altman-Z score of -0.42. This is a bad value and indicates that OCGN is not financially healthy and even has some risk of bankruptcy.

OCGN has a Altman-Z score of -0.42. This is comparable to the rest of the industry: OCGN outperforms 57.27% of its industry peers.

OCGN has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.

With a Debt to Equity ratio value of 0.07, OCGN is not doing good in the industry: 62.56% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	N/A
Altman-Z	-0.42

ROIC/WACCN/A

WACC9.1%

2.3 Liquidity

OCGN has a Current Ratio of 2.51. This indicates that OCGN is financially healthy and has no problem in meeting its short term obligations.

With a Current ratio value of 2.51, OCGN is not doing good in the industry: 73.16% of the companies in the same industry are doing better.

A Quick Ratio of 2.51 indicates that OCGN has no problem at all paying its short term obligations.

With a Quick ratio value of 2.51, OCGN is not doing good in the industry: 70.77% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Current Ratio	2.51
Quick Ratio	2.51

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

OCGN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.84%, which is quite impressive.

OCGN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 432.39% yearly.

EPS 1Y (TTM)36.84%

EPS 3YN/A

EPS 5YN/A

EPS growth Q2Q70%

Revenue 1Y (TTM)N/A

Revenue growth 3Y432.39%

Revenue growth 5YN/A

Revenue growth Q2QN/A

3.2 Future

The Earnings Per Share is expected to grow by 17.66% on average over the next years. This is quite good.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y-19%

EPS Next 2Y-5.12%

EPS Next 3Y27.32%

EPS Next 5Y17.66%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

OCGN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Also next year OCGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

OCGN's earnings are expected to grow with 27.32% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-5.12%

EPS Next 3Y27.32%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

OCGN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OCUGEN INC

NASDAQ:OCGN (5/6/2024, 1:42:06 PM)

1.6298

+0.3 (+22.54%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap419.40M

Analysts

Price Target

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Dividend Growth(5Y)

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA

EPS(TTM)

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-97.73%
ROE	-155.51%
ROCE
ROIC
ROICexc
ROICexgc
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.09

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio	2.51
Quick Ratio	2.51
Altman-Z

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

Growth

EPS 1Y (TTM)36.84%

EPS 3YN/A

EPS 5Y

EPS growth Q2Q

EPS Next Y-19%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)N/A

Revenue growth 3Y432.39%

Revenue growth 5Y

Revenue growth Q2Q

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y

OCUGEN INC (OCGN)

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens